Suchergebnisse - "Vermeire, S"

PubPharm (12)

1

Letter : vedolizumab drug levels in cord and maternal blood in women with inflammatory bowel disease-authors' reply

enthalten in: Alimentary pharmacology & therapeutics | 2018

von Mahadevan, U. | Vermeire, S. | Lasch, K. | +4

CommentOn: Aliment Pharmacol Ther. 2017 Apr;45(7):941-950. - PMID 28169436

2

Editorial : vedolizumab in pregnancy - is gut selectivity as good for baby as it is for mum? Authors' reply

enthalten in: Alimentary pharmacology & therapeutics | 2017

von Mahadevan, U. | Vermeire, S. | Lasch, K. | +4

CommentOn: Aliment Pharmacol Ther. 2017 Apr;45(7):941-950. - PMID 28169436

3

Vedolizumab exposure in pregnancy : outcomes from clinical studies in inflammatory bowel disease

enthalten in: Alimentary pharmacology & therapeutics | 2017

von Mahadevan, U. | Vermeire, S. | Lasch, K. | +4

CommentIn: Aliment Pharmacol Ther. 2017 May;45(9):1284. - PMID 28370036

4

Therapeutic innovations in inflammatory bowel diseases

enthalten in: Clinical pharmacology and therapeutics | 2016

von Vanhove, W. | Nys, K. | Vermeire, S.

5

Prior response to infliximab and early serum drug concentrations predict effects of adalimumab in ulcerative colitis

enthalten in: Alimentary pharmacology & therapeutics | 2014

von Baert, F. | Vande Casteele, N. | Tops, S. | +6

6

Adalimumab dose escalation and dose de-escalation success rate and predictors in a large national cohort of Crohn's patients

enthalten in: Journal of Crohn's & colitis | 2013

von Baert, F. | Glorieus, E. | Reenaers, C. | +57

7

Ustekinumab induction and maintenance therapy in refractory Crohn's disease

enthalten in: The New England journal of medicine | 2012

von Sandborn, W. | Gasink, C. | Gao, L. | +115

CommentIn: Nat Rev Gastroenterol Hepatol. 2012 Dec;9(12):690. - PMID 23147667

8

Commentary : BMI and the need for adalimumab dose escalation in Crohn's disease

enthalten in: Alimentary pharmacology & therapeutics | 2012

von Van Assche, G. | Baert, F. | Vermeire, S.

CommentOn: Aliment Pharmacol Ther. 2012 Feb;35(3):335-41. - PMID 22191671

9

The efficacy and safety of a third anti-TNF monoclonal antibody in Crohn's disease after failure of two other anti-TNF antibodies

enthalten in: Alimentary pharmacology & therapeutics | 2010

von Allez, M. | Vermeire, S. | Mozziconacci, N. | +14

10

Outcome of surgery for rectovaginal fistula due to Crohn's disease

enthalten in: The British journal of surgery | 2009

von Ruffolo, C. | Penninckx, F. | Van Assche, G. | +4